Status:
COMPLETED
Effects Of Detrol LA On Memory And Cognition In Elderly Population
Lead Sponsor:
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Conditions:
Memory
Cognition
Eligibility:
All Genders
65-75 years
Phase:
PHASE4
Brief Summary
The primary purpose of the trial is to show that tolterodine ER has no effect on memory and other cognitive abilities in an elderly population
Eligibility Criteria
Inclusion
- Male or female subjects with age of 65 - 75 years
- Having a score of greater than or equal to 26 on the Mini-Mental State Exam (MMSE)
Exclusion
- Current or history of bladder outlet obstruction. Previous history of acute urinary retention requiring catheterization, or severe voiding difficulties in the judgment of the investigator, prior to randomization
- Significant hepatic or renal disease, defined as twice the upper limit of the reference ranges regarding serum concentrations of AST, ALT, ALP, urea nitrogen, or creatinine
Key Trial Info
Start Date :
December 1 2006
Trial Type :
INTERVENTIONAL
End Date :
June 1 2007
Estimated Enrollment :
220 Patients enrolled
Trial Details
Trial ID
NCT00411437
Start Date
December 1 2006
End Date
June 1 2007
Last Update
January 27 2021
Active Locations (9)
Enter a location and click search to find clinical trials sorted by distance.
1
Pfizer Investigational Site
Tucson, Arizona, United States, 85741
2
Pfizer Investigational Site
Brooksville, Florida, United States, 34613
3
Pfizer Investigational Site
DeLand, Florida, United States, 32720
4
Pfizer Investigational Site
Naples, Florida, United States, 34102